Terms: = Breast cancer AND PR, PGR, progesterone receptor AND Treatment
5191 results:
1. breast cryoablation for the palliative treatment of indolent subtype of multicentric triple-negative breast cancer.
Huang ML; Lane DL; Bomar H; Kuerer H
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38627044
[TBL] [Abstract] [Full Text] [Related]
2. The HLA-I landscape confers prognosis and antitumor immunity in breast cancer.
Ding XH; Xiao Y; Chen F; Liu CL; Fu T; Shao ZM; Jiang YZ
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38602320
[TBL] [Abstract] [Full Text] [Related]
3. Significance of Estrogen/progesterone receptor Expression in Metaplastic breast Carcinoma.
Hashmi AA; Mallick BA; Rashid K; Malik UA; Zia S; Zia F; Irfan M
Dis Markers; 2024; 2024():2540356. PubMed ID: 38601434
[TBL] [Abstract] [Full Text] [Related]
4. Design and methods of the mobile assessment of cognition, environment, and sleep (MACES) feasibility study in newly diagnosed breast cancer patients.
Derbes R; Hakun J; Elbich D; Master L; Berenbaum S; Huang X; Buxton OM; Chang AM; Truica CI; Sturgeon KM
Sci Rep; 2024 Apr; 14(1):8338. PubMed ID: 38594369
[TBL] [Abstract] [Full Text] [Related]
5. Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer.
Bartoloni S; Pescatori S; Bianchi F; Cipolletti M; Acconcia F
Sci Rep; 2024 Apr; 14(1):8200. PubMed ID: 38589728
[TBL] [Abstract] [Full Text] [Related]
6. Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit.
Engström T; Ekholm M; Fernö M; Lundgren C; Nordenskjöld B; Stål O; Bendahl PO; Tutzauer J; Rydén L
Acta Oncol; 2024 Apr; 63():125-136. PubMed ID: 38587062
[TBL] [Abstract] [Full Text] [Related]
7. Neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy for human epidermal growth factor receptor 2 positive breast cancer: a real-world retrospective single-institutional study in China.
Peng DM; Li J; Qiu JX; Zhao L
World J Surg Oncol; 2024 Apr; 22(1):88. PubMed ID: 38582875
[TBL] [Abstract] [Full Text] [Related]
8. Effect of tumor-infiltrating immune cells (mast cells, neutrophils and lymphocytes) on neoadjuvant chemotherapy response in breast carcinomas.
Okcu O; Öztürk Ç; Yalçın N; Yalçın AC; Şen B; Aydın E; Öztürk AE
Ann Diagn Pathol; 2024 Jun; 70():152301. PubMed ID: 38581761
[TBL] [Abstract] [Full Text] [Related]
9. Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis.
Bahrin NWS; Matusin SNI; Mustapa A; Huat LZ; Perera S; Hamid MRWHA
Syst Rev; 2024 Apr; 13(1):100. PubMed ID: 38576013
[TBL] [Abstract] [Full Text] [Related]
10. Case report: Primary vulvar adenocarcinoma of mammary gland type-its genetic characteristics by focused next-generation sequencing.
Hu L; Tiesinga J
Pathol Oncol Res; 2024; 30():1611376. PubMed ID: 38572338
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study.
Peng J; Hong Y; Chen Q; Xu F; Zhang D; Yao J; Zou Q; Yuan L; Li L; Long Q; Liao L; Liu M; Liu X; Wang S; Yi W
Front Endocrinol (Lausanne); 2024; 15():1347762. PubMed ID: 38567311
[TBL] [Abstract] [Full Text] [Related]
12. The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer.
Ye JH; Yu J; Huang MY; Mo YM
Breast Cancer; 2024 May; 31(3):417-425. PubMed ID: 38561479
[TBL] [Abstract] [Full Text] [Related]
13. Proliferation Patterns of MCF-7 breast cancer Cells in Lipoaspirate Conditioned Media.
Chen Y; Arbuiso S; Qin N; Vernice NA; Black GG; Brown KA; Otterburn D
Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S207-S209. PubMed ID: 38556675
[TBL] [Abstract] [Full Text] [Related]
14. pgr-KITLG signaling drives a tumor-mast cell regulatory feedback to modulate apoptosis of breast cancer cells.
Yang Z; Chen H; Yin S; Mo H; Chai F; Luo P; Li Y; Ma L; Yi Z; Sun Y; Chen Y; Wu J; Wang W; Yin T; Zhu J; Shi C; Zhang F
Cancer Lett; 2024 May; 589():216795. PubMed ID: 38556106
[TBL] [Abstract] [Full Text] [Related]
15. Potential Value of HSP90α in Prognosis of Triple-Negative breast cancer.
Wang HF; Chen Y; Cao B; Pei J
Med Sci Monit; 2024 Mar; 30():e943049. PubMed ID: 38553816
[TBL] [Abstract] [Full Text] [Related]
16. Case report: A case of Paget disease outside the axillary breast.
Zhou Z; Zhou B; Wu X; Wei W
Medicine (Baltimore); 2024 Mar; 103(13):e37541. PubMed ID: 38552095
[TBL] [Abstract] [Full Text] [Related]
17. Human Epidermal Growth Factor receptor 2-Low breast cancer Brain Metastases: An Opportunity for Targeted Systemic Therapies in a High-Need Patient Population.
Chehade R; Nofech-Mozes S; Plotkin A; Fan KY; Das S; Sahgal A; Moravan V; Jerzak KJ
JCO Precis Oncol; 2024 Mar; 8():e2300487. PubMed ID: 38547418
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study.
Yu Y; Huang K; Liu Y; Chen R; Yu X; Song C
BMC Geriatr; 2024 Mar; 24(1):282. PubMed ID: 38528444
[TBL] [Abstract] [Full Text] [Related]
19. Targeting human progesterone receptor (PR), through pharmacophore-based screening and molecular simulation revealed potent inhibitors against breast cancer.
Shahab M; Ziyu P; Waqas M; Zheng G; Bin Jardan YA; Fentahun Wondmie G; Bouhrhia M
Sci Rep; 2024 Mar; 14(1):6768. PubMed ID: 38514638
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients.
Wang M; Wei Z; Kong J; Zhao H
Diagn Pathol; 2024 Mar; 19(1):53. PubMed ID: 38509525
[TBL] [Abstract] [Full Text] [Related]
[Next]
